In some ways MSB only survives still due to the shorts making $$ while providing capital for MSB to continue operations.
Might be why they say "Be careful what you wish for".
Of course, once MSB becomes profitable there will no longer be any need to raise capital.
Is it the shorters who are the enemy or the FDA stretching things out.
With ALL of the various companies running stem cell trials why is it only MSB being told not to run any trials util the MOA and batch consistency issues are sorted out? Hmmm?
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-16780
-
- There are more pages in this discussion • 1,136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7329 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.0¢ | 2290 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7329 | 1.015 |
1 | 173 | 1.005 |
1 | 962 | 1.000 |
3 | 75522 | 0.990 |
2 | 691 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 2290 | 2 |
0.925 | 16144 | 1 |
0.935 | 5935 | 1 |
0.940 | 4609 | 2 |
0.970 | 103 | 1 |
Last trade - 10.04am 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online